Insider filing · IDXX
Michael Lane
Executive Vice President
profile →
IDEXX Laboratories, Inc.
IDXX · Healthcare · 39 filings in 24 months
ticker →
Michael Lane sold $5.3M of IDEXX Laboratories (IDXX)
Executed Aug 6 2025, disclosed Aug 8 2025, 2 days later.
Value, as filed
$5.3M
8,411 sh across 3 lots
Executed
Aug 6 2025
the trade date, as filed
Disclosed
Aug 8 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MLMichael Lane (Executive Vice President) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in IDEXX Laboratories, Inc. (IDXX). The largest single filing was $2.7M of IDXX (3,979 sh across 3 lots, as filed), executed Nov 4.
The name
IDXXHealthcare · IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Michael Lane in IDXX
IDXXSALE
IDEXX Laboratories, Inc.
$2.7M3,979 sh across 3 lots
Exec Nov 4
Filed Nov 5 · 5:01 PM ET